Literature DB >> 24820409

Photodynamic therapy: current status and future directions.

Ludmil Benov1.   

Abstract

Photodynamic therapy (PDT) is a minimally invasive therapeutic modality used for the management of a variety of cancers and benign diseases. The destruction of unwanted cells and tissues in PDT is achieved by the use of visible or near-infrared radiation to activate a light-absorbing compound (a photosensitizer, PS), which, in the presence of molecular oxygen, leads to the production of singlet oxygen and other reactive oxygen species. These cytotoxic species damage and kill target cells. The development of new PSs with properties optimized for PDT applications is crucial for the improvement of the therapeutic outcome. This review outlines the principles of PDT and discusses the relationship between the structure and physicochemical properties of a PS, its cellular uptake and subcellular localization, and its effect on PDT outcome and efficacy.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820409      PMCID: PMC6489067          DOI: 10.1159/000362416

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  78 in total

1.  Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.

Authors:  Qilai Long; Tzu-Yin Lin; Yee Huang; Xiaocen Li; Ai-Hong Ma; Hongyong Zhang; Randy Carney; Susan Airhart; Kit S Lam; Ralph W deVere White; Chong-Xian Pan; Yuanpei Li
Journal:  Nanomedicine       Date:  2018-01-06       Impact factor: 5.307

Review 2.  Photothrombotic Stroke as a Model of Ischemic Stroke.

Authors:  Anatoly B Uzdensky
Journal:  Transl Stroke Res       Date:  2017-11-29       Impact factor: 6.829

3.  Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX.

Authors:  Christine Cruz-Oliveira; Andreza F Almeida; João M Freire; Marjolly B Caruso; Maria A Morando; Vivian N S Ferreira; Iranaia Assunção-Miranda; Andre M O Gomes; Miguel A R B Castanho; Andrea T Da Poian
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  Nanoscale Metal-Organic Frameworks for Phototherapy of Cancer.

Authors:  Guangxu Lan; Kaiyuan Ni; Wenbin Lin
Journal:  Coord Chem Rev       Date:  2017-10-21       Impact factor: 22.315

5.  Lowering photosensitizer doses and increasing fluences induce apoptosis in tumor bearing mice.

Authors:  Katja Haedicke; Susanna Graefe; Ulf Teichgraeber; Ingrid Hilger
Journal:  Biomed Opt Express       Date:  2016-06-16       Impact factor: 3.732

6.  Bystander effects of nitric oxide in anti-tumor photodynamic therapy.

Authors:  Jerzy Bazak; Jonathan M Fahey; Katarzyna Wawak; Witold Korytowski; Albert W Girotti
Journal:  Cancer Cell Microenviron       Date:  2017-02-27

7.  Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.

Authors:  Jonathan M Fahey; Albert W Girotti
Journal:  Nitric Oxide       Date:  2016-12-19       Impact factor: 4.427

8.  Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge.

Authors:  Albert W Girotti
Journal:  Crit Rev Oncog       Date:  2016

9.  Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms.

Authors:  Yuxia Tang; Ying Liu; Shouju Wang; Ying Tian; Yanjun Li; Zhaogang Teng; Guangming Lu
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

10.  Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.

Authors:  John A Roque; Patrick C Barrett; Houston D Cole; Liubov M Lifshits; Evan Bradner; Ge Shi; David von Dohlen; Susy Kim; Nino Russo; Gagan Deep; Colin G Cameron; Marta E Alberto; Sherri A McFarland
Journal:  Inorg Chem       Date:  2020-10-30       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.